KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Thermo Fisher Scientific (TMO) Debt to Equity (2016 - 2026)

Thermo Fisher Scientific filings provide 18 years of Debt to Equity readings, the most recent being $0.83 for Q1 2026.

  • On a quarterly basis, Debt to Equity rose 19.98% to $0.83 in Q1 2026 year-over-year; TTM through Mar 2026 was $0.83, a 19.98% increase, with the full-year FY2025 number at $0.74, up 16.82% from a year prior.
  • Debt to Equity hit $0.83 in Q1 2026 for Thermo Fisher Scientific, up from $0.74 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.83 in Q2 2023 to a low of $0.63 in Q4 2024.
  • Median Debt to Equity over the past 5 years was $0.75 (2024), compared with a mean of $0.74.
  • Biggest five-year swings in Debt to Equity: skyrocketed 52.49% in 2022 and later dropped 15.54% in 2024.
  • Thermo Fisher Scientific's Debt to Equity stood at $0.78 in 2022, then dropped by 4.59% to $0.75 in 2023, then dropped by 15.54% to $0.63 in 2024, then increased by 16.82% to $0.74 in 2025, then grew by 12.71% to $0.83 in 2026.
  • The last three reported values for Debt to Equity were $0.83 (Q1 2026), $0.74 (Q4 2025), and $0.7 (Q3 2025) per Business Quant data.